Back to search
FDAFDA · Food and drugs·Recall number D-0023-2017

Amikacin Sulfate Injection, USP, 500 mg/2 mL (250 mg/mL) Rx Only, Manufactured in Hungary For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-9032-01 (individual pack), NDC 0703-9032-03 (shelf-pack carton of 10 vials).

Published October 19, 2016 · Recall initiated: July 29, 2016

Summary

FDA records drug Class II recall D-0023-2017, published October 19, 2016 and initiated July 29, 2016. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 27,547 vials; Lot: Lot # 7080315, 7400315, 7410315, 7980415. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide and Puerto Rico
Lot
Lot # 7080315, 7400315, 7410315, 7980415
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Amikacin Sulfate Injection, USP, 500 mg/2 mL (250 mg/mL) Rx Only, Manufactured in Hungary For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0703-9032-01 (individual pack), NDC 0703-9032-03 (shelf-pack carton of 10 vials). recalled?

Yes. FDA published recall D-0023-2017 on October 19, 2016. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter